|
|
Focus on The Pharmaceutical Industry 2008: Current and Future Trends and Strategic Issues Shaping Pharma
|
Focus on The Pharmaceutical Industry 2008: Current and Future Trends and Strategic Issues Shaping Pharma
|
Aastrom Reports Third Quarter Fiscal Year 2008 Financial Results
|
Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in V
|
Focus on The Pharmaceutical Industry 2008: Current and Future Trends and Strategic Issues Shaping Pharma
|
H&Q Life Sciences Investors Declares Stock Distribution
|
Corcept Therapeutics Announces First Quarter 2008 Results
|
Stellar Pharmaceuticals Inc. Provides Update on Normal Course Issuer Bid & Provides Company Updates
|
Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offer
|
Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offer
|
Biosimilars Are Poised to Infl
|
Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offer
|
BUYINS.NET: (SCRX) SqueezeTrigger Price is $19.582. There is $222,145,872.00 That Short Sellers Still Need To
|
Jazz Pharmaceuticals, Inc. Secures $75 Million Committed Equity Financing Facility
|
AIG's loss and record oil sour mood on Wall St
|
Ym Biosciences Reports Fiscal Third Quarter 2008 Operational And Financial Results
|
The Canadian Press Business News Budget, Thursday, May 8, 2008
|
The Canadian Press Business News Budget, Thursday, May 8, 2008
|
Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offer
|
Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offer
|
